Enzo Life Sciences is a recognized leader in technologies for cellular analysis, assay development, molecular biology, and proteostasis. Our diverse portfolio of fluorescent labels & dyes, ELISA and enzyme activity assays, biochemicals, antibodies, and proteins serves the life sciences research, drug discovery & development, and clinical research markets. Our products facilitate discovery in cancer, neuroscience, cellular stress, immunology, screening and lead identification, toxicology, bioprocess optimization, and clinical diagnostics.
We are scientists enabling scientists™. For over 30 years, Enzo Life Sciences has been providing the life sciences market with a unique array of fluorescent probes, dyes, and labeling systems for molecular biology and cellular analysis. Our acquisition of ALEXIS® Biochemicals, BIOMOL® International, Assay Designs® and Stressgen® Bioreagents has incorporated the skills and scientific expertise of these industry-established providers of bioreagents, chemicals, and assay kits.
Enzo Life Sciences now offers a diverse portfolio of over 9000 products and services including: more than 300 immunoassay and enzyme activity assays for biomarker quantification and compound screening; compound libraries composed from our collection of over 3500 chemical compounds including FDA approved drugs, known bioactives, natural products, and pathway-targeted collections; a broad portfolio of innovative CELLestial® assay kits for live cell analysis, including kits for early assessment of in vitro cytotoxicity and ProteoStat® dyes for detection of protein aggregates; robust array cGH labeling kits for detecting DNA copy number gains and losses; and custom services, featuring contract assay development backed by our assay development and manufacturing expertise and world class reagents.